| Funding Opportunity ID: |
313355 |
| Opportunity Number: |
RFA-AG-19-030 |
| Opportunity Title: |
Limited Competition: Renewal of the Aging Interventions Testing Program (U01 Clinical Trial Not Allowed) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.866 |
| Eligible Applicants: |
Public and State controlled institutions of higher education |
| Additional Information on Eligibility: |
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see the funding announcement for eligibility details |
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
Mar 01, 2019 |
| Close Date: |
May 01, 2019 |
| Last Updated Date: |
Mar 01, 2019 |
| Award Ceiling: |
$3,000,000 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
|
| Expected Number of Awards: |
|
| Description: |
The Aging Interventions Testing Program (ITP) tests, under standardized conditions, potential intervention strategies which may decelerate the rate of aging in mammals. The rate of aging is to be measured by lifespan extension and/or improvements in health at later ages due to the intervention. The ITP has used lifespan as its primary outcome for an intervention, with limited studies on end-of-life pathologies and selected tests of health across the lifespan (health span). This FOA calls for renewal of the ITP with the following goals: 1) Continue to test compounds for effects on lifespan; 2) Increase histology and pathophysiology analyses at time of death; 3) Increase focused studies of health span on selected compounds. |
| Version: |
1 |
